Farquharson Andrew
SEC CIK 1865699 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RANI | Rani Therapeutics Holdings, Inc. | Dir | 72.8K | — | $853.7K | 5 | 2022-02-03 | 2022-08-23 |
Most active insiders at RANI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | South Cone Investments Limited Partnership | 10% | — | $15.71M |
| 2 | IMRAN MIR A | Dir, 10% | $1.30M | — |
| 3 | Imran Talat | CEO, Dir | $25.2K | — |
| 4 | Javadi Alireza | Chief Technical Off | — | $301.08 |
Farquharson Andrew made no open-market trades at RANI in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2022-08-25 | 2022-08-23 | RANI | Rani Therapeutics Holdings, Inc. | Farquharson Andrew | Dir | C - Cnv Deriv | $0.00 | 0 | 72.8K | New | $0 |
| MI | 2022-08-19 | 2022-08-17 | RANI | Rani Therapeutics Holdings, Inc. | Farquharson Andrew | Dir | S - Sale | $10.64 | -80.3K | 65.1K | -55% | -$853.7K |
| DMI | 2022-03-10 | 2022-03-07 | RANI | Rani Therapeutics Holdings, Inc. | Farquharson Andrew | Dir | C - Cnv Deriv | $0.00 | 0 | 2.38M | New | $0 |
| DI | 2022-03-10 | 2022-03-07 | RANI | Rani Therapeutics Holdings, Inc. | Farquharson Andrew | Dir | J - Other | $0.00 | -2.23M | 146.4K | -94% | $0 |
| MI | 2022-02-07 | 2022-02-03 | RANI | Rani Therapeutics Holdings, Inc. | Farquharson Andrew | Dir | J - Other | $0.00 | -761.3K | 66.1K | -92% | $0 |
Purchase Sale Sale after option exercise All abbreviations